Cassava Sciences
Last update: November 15, 2019
Pharmaceuticals
United States (USA)
Its 11 main executives
Create an alert
to follow the executive moves at Cassava Sciences.
Latest M&A news in Pharmaceuticals.
Zyla Life Sciences and Assertio Therapeutics have announced they will merge (posted on Mar 17, 2020).
Dermapharm has announced the acquisition of Allergopharma (posted on Feb 19, 2020).
Qualigen has announced the acquisition of Ritter Pharmaceuticals (posted on Jan 21, 2020).
Most searched biographies at Cassava Sciences
- Remi Barbier, Chairman of the Board, President, Chief Executive Of...
- Patrick Scannon, Director
- Robert Gussin, Director
Click on an executive to view his biography >
Other contacts in the Pharmaceuticals industry
Latest news about Cassava Sciences
Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020 | Cassava Sciences, Inc.
Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s Disease | Cassava Sciences, Inc.
Cassava Sciences Announces Clinical Update and Business Progress Across Neuroscience Pipeline | Cassava Sciences, Inc.
Cassava Sciences Announces Phase 2a Study of PTI-125 Published in The Journal of Prevention of Alzheimer’s Disease (JPAD) | Cassava Sciences, Inc.
Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease | Cassava Sciences, Inc.
Cassava Sciences on Wikipedia, Google News & Yahoo Finance
Cassava Sciences on LinkedIn, Twitter & YouTube
Cassava Sciences has 1,978 competitors including Johnson & Johnson (United States (USA)), Sanofi (France) and Roche (Switzerland).
Contact by email its executives including Eric Schoen 
Call Cassava Sciences at +1 512....
